126063-08-9

Basic information

• Product Name: AcetaMide, 2,2,2-trifluoro-N-(4-iodophenyl)-
• Synonyms: AcetaMide, 2,2,2-trifluoro-N-(4-iodophenyl)-
• CAS NO: 126063-08-9
• Molecular Formula: C₈H₅F₃INO
• Molecular Weight: 315.0310796
• Mol File: 126063-08-9.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: AcetaMide, 2,2,2-trifluoro-N-(4-iodophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: AcetaMide, 2,2,2-trifluoro-N-(4-iodophenyl)-(126063-08-9)
• EPA Substance Registry System: AcetaMide, 2,2,2-trifluoro-N-(4-iodophenyl)-(126063-08-9)

Safety Data

• Hazardous Substances Data: 126063-08-9(Hazardous Substances Data)

Upstream product

• 404-24-0 2,2,2-trifluoro-N-phenylacetamide 
• 407-25-0 trifluoroacetic anhydride 
• 540-37-4 p-aminoiodobenzene 
• 1236874-98-8 2,2,2-trifluoro-N-(4-iodophenyl)ethanethioamide 
• 1068660-05-8 4-iodophenyl trifluoroacetimidochloride 

Downstream Products

• 158074-65-8 4-(4-aminophenyl)-2-methyl-3-butyn-2-ol trifluoroacetamide 
• 404-26-2 4-(trifluoroacetamido)benzoic acid 
• 14235-81-5 4-Ethynylaniline 
• 312745-68-9 Δ-4H-2-(4-aminophenyl)-6-phenylthiopyran-4-one 
• 312745-65-6 1-(4-ethynylphenyl)-2,2,5,5-tetramethyl-1,2,5-azadisilolidine 
• 312745-69-0 Δ-4H-2-(4-aminophenyl)-6-phenylselenopyran-4-one 
• 312745-70-3 Δ-4H-2-(4-aminophenyl)-6-phenyltelluropyran-4-one 
• 312745-66-7 1-[4-(N,N-(dimethylsilylethano)amino)phenyl]-5-phenyl-1,4-pentadiyn-3-ol 
• 312745-67-8 1-[4-(N,N-(dimethylsilylethano)amino)phenyl]-5-phenyl-1,4-pentadiyn-3-one 
• 59-30-3 folic acid 
• 4271-30-1 N-(4-aminobenzoyl)-L-glutamic acid 
• 119-24-4 pteroic acid 
• 150-13-0 4-amino-benzoic acid 
• 2544-29-8 N⁽²⁾-acetylfolic acid 

Relevant articles and documents

A Simple and Economical Synthetic Route to p-Ethynylaniline and Ethynyl-Terminated Substrates

-

BI-FUNCTIONAL QUINOLINE ANALOGS

Provided are compounds of Formula I: wherein X is: R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.

Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors

The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I: or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.